Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Active, not recruiting · NCT06253663 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-06-25 | NCT06253663 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kite, A Gilead Company | 27 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chiba University Hospital | Chiba | Japan | 22 |
| Hokkaido University Hospital | Hokkaido | Japan | 1 |
| Juntendo University Hospital | Tokyo | Japan | 26 |
| Kyoto University Hospital | Kyoto | Japan | 56 |
| Kyushu University Hospital | Fukuoka | Japan | 53 |
| National Cancer Center Hospital | Tokyo | Japan | 42 |
| Okayama University Hospital | Okayama | Japan | 75 |
| Tohoku University Hospital | Miyagi | Japan | 16 |
| Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital | Tokyo | Japan | 3 |